Akèy › Maladi selil fòs › North Carolina
Etid klinik pou Maladi selil fòs nan North Carolina
18 etid pou Maladi selil fòs ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- East Carolina University, Greenville
- Wake Forest University Baptist Medical Center, Winston-Salem
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Duke University Medical Center, Durham
- Brody School of Medicine at East Carolina University, Greenville
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Atrium Levine Children's/Atrium Health, Charlotte
- Duke University_Durham, Durham
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Duke Comprehen Sickle Cell, Durham
- Duke University Medical Center, Durham
- East Carolina Univ-Greenville, Greenville
- ak 1 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- Levine Cancer Insitute Carolinas Healthcare System, Charlotte
- East Carolina University, Greenville
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 12 a 55 · Tout sèks · Mizajou Sep 9, 2026 · NCT06546670A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0033, Greenville
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Clinical & Translational Research Center (CTRC), Chapel Hill
- UNC Health, Chapel Hill
- UNC Eastowne Medical Office Building - Consent Only, Chapel Hill
- ak 4 plis
Ap rekriteFaz 2/3
Laj 12 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill
- St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital, Charlotte
- East Carolina University Hemophilia Treatment Center, Greenville
- ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- East Carolina University, Greenville
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06699849Sickle Cell Clinical Research and Intervention Program
- Novant Health Hemby Children's Hospital, Charlotte
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 4, 2026 · NCT02098863Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- UNC Children's Hospital (MRD HCT), Chapel Hill
- UNC Children's Hospital (NT-DMT), Chapel Hill
- Atrium Health (MRD-HCT), Charlotte
Ap rekriteEtid obsèvasyon
Laj 3 a 20 · Tout sèks · Mizajou Jun 4, 2026 · NCT06941389SickleFit Exercise and Nutrition Study
- Duke University, Durham
Ap rekrite
Laj 35 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT07442851Predictors of Pain in Sickle Cell Disease
- Duke University Medical Center, Durham
Ap rekrite
Laj 15 a 40 · Tout sèks · Mizajou May 5, 2026 · NCT06139510ATHNdataset Registry
- American Thrombosis and Hemostasis Network, Hickory
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 21, 2026 · NCT06820515Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- Levine Children's Hospital - Hematology, Charlotte
Ap rekriteFaz 3
Laj 12 a 35 · Tout sèks · Mizajou Mar 23, 2026 · NCT05477563Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Duke University Medical Center, Durham
Ap rekriteFaz 2
Laj 15 a 40 · Tout sèks · Mizajou Mar 13, 2026 · NCT06260891Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Levine Children's Hospital, Charlotte
Ap rekriteFaz 2
Laj 2 a 25 · Tout sèks · Mizajou Mar 10, 2026 · NCT03587272Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Wake Forest Baptist Hospital, Durham
- East Carolina University Health Medical Center, Greenville
Ap rekrite
Laj 16 a 30 · Tout sèks · Mizajou Jan 7, 2026 · NCT06374238Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.